To develop early-stage antibiotic lead compounds discovered by researchers at Utrecht University. Specifically, we aim to target clinically-relevant pathogenic bacteria that have become resistant to first-line antibiotics.

Molecular diagnostics products for chimerisme monitoring

Levels Dx is using activated immune cells as biomarkers to allow an accurate diagnosis of a bacterial infection in patients. The Rapid Diagnostic Tool (RDT) will provide accurate results within minutes and is portable.

We have developed a new, potent anticancer therapy with minimal side effects, as it has two levels of selectivity: a nanobody that directs a light-activatable drug to cancer cells, and light locally applied at the tumor to activate the drug.

Developing an innovative targeted immunotherapy against cancer using remote controlled conditional attenuated bacteria.

Diagnostic and treatment device for pelvic floor dysfunctions, such as prolapse, micturition, defecation and urinary and faecal incontinence

MedicalVR’s PulmoVR innovation enables thoracic surgeons to cure patients with lung cancer by preventing the unnecessary removal of healthy lung tissue, resulting in a ‘lung-sparing surgical procedure’ for lung cancer.

We firmly believe that everybody has the basic human right to live without the limitations of disease. Therefore, we aim to provide patients with new treatment options that add true value and allow them to break free from those limitations.

From Genes to Pathways to Novel Drugs For Multiple Sclerosis

Preventing pressure ulcers with smart monitoring